TipRanks
Advertisement
Advertisement
ArcticZymes bolsters board to drive RNA and gene therapy strategy
PremiumCompany AnnouncementsArcticZymes bolsters board to drive RNA and gene therapy strategy
4M ago
ArcticZymes Shareholders Approve All Proposals at 2026 AGM
Premium
Company Announcements
ArcticZymes Shareholders Approve All Proposals at 2026 AGM
4M ago
ArcticZymes Chair to Represent Over 11% of Shares at 2026 AGM
Premium
Company Announcements
ArcticZymes Chair to Represent Over 11% of Shares at 2026 AGM
4M ago
ArcticZymes Publishes 2025 Annual and ESG Reports in ESEF Format
PremiumCompany AnnouncementsArcticZymes Publishes 2025 Annual and ESG Reports in ESEF Format
5M ago
ArcticZymes Wins Key Patent to Drive Expansion in RNA Therapeutics Manufacturing
Premium
Company Announcements
ArcticZymes Wins Key Patent to Drive Expansion in RNA Therapeutics Manufacturing
5M ago
ArcticZymes Deepens Bioprocessing R&D to Boost Viral Vector Manufacturing
Premium
Company Announcements
ArcticZymes Deepens Bioprocessing R&D to Boost Viral Vector Manufacturing
5M ago
ArcticZymes Sets Out Scalable Enzyme Growth Strategy at 2026 Capital Markets Day
PremiumCompany AnnouncementsArcticZymes Sets Out Scalable Enzyme Growth Strategy at 2026 Capital Markets Day
8M ago
ArcticZymes Sets Date for 2025 Results and Capital Markets Day
Premium
Company Announcements
ArcticZymes Sets Date for 2025 Results and Capital Markets Day
8M ago
ArcticZymes Completes Share Buy-Back for Employee Program
Premium
Company Announcements
ArcticZymes Completes Share Buy-Back for Employee Program
10M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―